Lung Health & Disease

The University of Rochester has an outstanding history of leadership in pediatric respiratory disease research, including being at the forefront of the development and implementation surfactant replacement therapy. Surfactant replacement was a revolutionary therapy that has been responsible for saving the lives of countless premature infants since its development. Current research continues this legacy of research excellence by defining normal processes involved in lung development, and how  genetic and environmental factors that impair lung development cause respiratory disease in children. These studies include basic research on the function of cells and molecules in lung health and disease, investigation of animal models of respiratory disease, and translational studies including analyses of human subjects and subject-derived bio-specimens.

Investigators